AMBEEPHA

Ambee Pharmaceuticals PLC · Pharmaceuticals and Chemicals · Cat A

0/100

High risk

৳768.7

DSE Hexagon

Stands out for constructive price action, held back by looks fully priced.

Six lenses, each scored 0–100 from the analysis. Integrity is DSE-specific — it reads how organic the price action is (high = clean, low = concentrated-operator risk). Descriptive only, not a recommendation.

Risks & rewards

Risks (2)

⚠ Earnings trending down
⚠ Financial health deteriorating

Rewards (1)

✓ Strong return on equity (16%)

Score breakdown

Price history & performance

52-week high৳894.6

52-week low৳698.2

From 52w high-14.1%

Beta0.39

7D +1.6%

1M -0.7%

3M -2.3%

6M +8.6%

1Y -5.5%

YTD +7.0%

Shareholder returns vs DSEX

AMBEEPHA+0.6%

DSEX+2.4%

AMBEEPHA underperformed the DSEX since Jul 8, 2026 — that's when we started tracking the index, so this window will get longer over time.

Volatility

Annualized volatility38.8%

Daily VaR (95%)-3.44%

Max drawdown (5y)-45.5%

Correlation to market0.36

Typical volatility for a DSE stock. Descriptive only — past volatility is not a forecast.

Technical read

RSI (14)54.7

MACDbullish

Bollingerinside bands (+1.1σ)

Price cycle (Wyckoff)MARKUP

Health trenddeteriorating

Flow pressuredistribution

Valuation

Fair value ()

Upside—

Dividend yield+0.10%

Fundamental verdictSUSTAINABLE

Confidence—

Ownership

Institutional holding5.83%

Foreign holding0.0%

Free float16.92%

Sponsor, institutional, foreign and public holdings from the latest disclosed shareholding pattern. Descriptive only.

Share structure

Authorized capital৳300mn

Paid-up capital৳24mn

Face value৳10

Market lot1

Outstanding shares2,400,000

Last AGM18-12-2025

Fiscal year end30-Jun

Reserve & surplus (ex-OCI)৳8.3mn

Other comprehensive income৳0mn

Financials

Recent P/E ratio

DateCurrent P/ETrailing P/E

Jul 14, 2026 256.06 335.48

Jul 13, 2026 255.1 334.22

Jul 12, 2026 251.38 329.35

Jul 9, 2026 252.44 330.74

Jul 8, 2026 253.67 332.35

Jul 7, 2026 258.22 338.3

Based on the latest un-audited financial statements. Descriptive only.

Dividend history

202510%

202410%

202315%

202210%

202015%

201930%

201830%

201730%

201626%

Earnings & NAV

YearEPSNAVDividend

2025 2.21 13.47 10%

2024 4.03 12.26 10%

2023 3.76 9.73 15%

2022 3.36 21.96 10%

Quarterly EPS — FY2026

Q10.5

Q21.36

Half-year1.86

Q30.4

Nine-month2.26

From disclosed annual reports and dividend declarations. Descriptive only, not a forecast.

Levels

Resistance

৳776.7

৳810

৳834.9

৳868.9

Support

৳767.2

৳740

৳715.1

৳685

Historical bounce zones

Sep 5, 2024: ৳861.3→৳999 +16%

Oct 8, 2024: ৳757.2→৳895 +18%

Jan 16, 2025: ৳675→৳799.9 +19%

Feb 27, 2025: ৳719→৳947.9 +32%

May 27, 2025: ৳738.3→৳869 +18%

Jun 22, 2025: ৳790→৳929 +18%

Nov 2, 2025: ৳701→৳829 +18%

Dec 18, 2025: ৳681→৳821 +21%

Sector peers

Other Pharmaceuticals and Chemicals names, ranked by our analysis score (DSE has no market-cap feed). Descriptive comparison only.

ScripScorePriceUpsideYield

IBNSINAThe IBN SINA Pharmaceutical Industry PLC 87 ৳326.5 +12.00% +2.00%MARICOMarico Bangladesh Limited 87 ৳2,732.4 +24.00% +2.20%SQURPHARMASquare Pharmaceuticals PLC. 85 ৳221.4 +120.00% +5.40%ACMELABThe ACME Laboratories Limited 79 ৳86.9 +138.00% +4.10%BXPHARMABeximco Pharmaceuticals PLC. 78 ৳153.2 +54.00% +2.60%RENATARenata PLC 64 ৳464.3 -25.00% +1.20%

Historical outlook

Based on how similar setups behaved historically — not a prediction of what will happen.

10-day 40% vs 40% market avg Typical move: -5.1% / -1.2% / 4%

30-day 41% vs 42% market avg Typical move: -8.8% / -1.9% / 6.6%

Signals: Price reclaims MA200|Bullish Engulfing

Reference levels

Descriptive reference points from the analysis — not instructions to buy or sell.

Entry readAVOID (no entry)

Reference stopif held: EXIT now / close<760.5

Reference target—

Timing noteexit / stay out

Elevated (score 191) — acceptable only with real earnings and sponsor backing; artificial-activity lens applies. Phase: DUMPING (0% >200-MA, flow DIST). SLOW-BURN evasion: +112% stretch / 155% run on only 0 circuits — score UNDER-rates it; consistent with concentrated-operator-style behaviour. ⚠ SOLVENCY DISTRESS (Altman Z -0.93, DETERIORATING) — bankruptcy risk. high-risk. [fundamentals SUSTAINABLE, payout 45.0%, yield 0.1%]